Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Banyu presents new series of biarylurea CDK inhibitors as antineoplastic agents

March 20, 2001

Merck describes synthesis and use of new inhibitors of Ras prenylation

March 20, 2001

Heptapeptide LHRH antagonists in the Abbott pipeline

March 19, 2001

Antisense oligonucleotides designed at Isis to modulate Akt-3

March 19, 2001

Abbott and NaPro BioTherapeutics file ANDA for paclitaxel

March 19, 2001

Liposomal FGF-2 vaccine shows antiangiogenic efficacy

March 19, 2001

Somatostatin receptor modulators designed at SCRAS

March 16, 2001

Bioenvision announces codevelopment partner for clofarabine

March 16, 2001

Marketing application filed in Australia for PhotoCure's Metvix PDT

March 16, 2001

Id4 identified as regulator of BRCA1 expression

March 16, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...